Mostrando 3 resultados de: 3
Subtipo de publicación
Article(3)
Área temáticas
Enfermedades(2)
Medicina forense; incidencia de enfermedades(2)
Problemas sociales y servicios a grupos(2)
Farmacología y terapéutica(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Origen
scopus(3)
Clinical characteristics, systemic complications, and in-hospital outcomes for patients with COVID-19 in Latin America. LIVEN-Covid-19 study: A prospective, multicenter, multinational, cohort study
ArticleAbstract: Purpose The COVID-19 pandemic has spread worldwide, and almost 396 million people have been infectedPalabras claves:Autores:Aguilar Á., Angel J.M., Aponte C.V., Arango A.J., Arias L.F.M., Ayala A.L., Bastidas A., Bayona A.V., Birri N.R., Bravo J.V., Bravo L., Bruhn A., Buitrago R., Bustos I.G., Cabrera M.V.M., Caceres E.L., Calderón L.E., Carvajal V.E.P., Casanova J.P.M., Castro-Lara J., Chaar A.J., Chávez-Villegas J., Cruz J.D., Cucunubo L., de los Angeles Caiza Mosquera S., Díaz A.M., Espinosa M.A.J., Estenssoro E., Estrada C.A., Forero-Carreño C., Franco F., Freire H.A.S., Friedman G., Fuentes Y.V., Galindo M.A.T., Gallegos X.A.N., Gamboa E., García F., García L., García-Gallo E., Gomez S., Gorordo-Delsol L.A., Hernandez G., Holguin D., Ibáñez-Prada E.D., López-Reveles L.A., Loudet C., Lozada J., Luis Javier Unigarro, Mamani L.F., Mantilla K.A., Manuel Jibaja, Maraschin F., Martín-Loeches I., Martinez L.E.T., Moncayo J.V., Montaño G.S., Morales E.S.E., Moya H.H., Muñoz C.S., Narváez P.O., Nin Vaeza N., Ortíz G., Ortíz V., Ospina-Tascón G.A., Pabón L., Palma D.A.M., Parra-Tanoux D., Peláez C., Picoita F., Pinedo J.A., Poveda M., Quevedo V.C., Ramirez P., Ramírez V., Reyes L.F., Rodríguez A., Rodríguez F., Romero C., Saenz M.G., Saenz-Valcarcel M., Sánchez A.R.B., Sanchez F.R., Sánchez H., Sánchez P., Saucedo L.M., Serrano-Mayorga C.C., Silva E., Solis J.A.C., Troya J.A.M., Trujillo D., Tutillo D.R.M., Vargas N.G.R., Varón-Vega F., Vera-Alarcon M., Vinueza L.E.M., Yupa M.L.Fuentes:scopusDexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
ArticleAbstract: Purpose: Dexamethasone is the only drug that has consistently reduced mortality in patients with COVPalabras claves:covid-19, Critical care, Dexamethasone, Pneumonia, Severe COVID-19Autores:Albaya-Moreno A., Bastidas A., Bodí M., Díaz A.M., Díaz E., Estella A., Ferrer R., Fuentes Y.V., García-Gallo E., Hernandez G., Jorge-García R., Loza-Vazquez A., Manuel Jibaja, Martín-Loeches I., Moreno G., Ospina-Tascón G.A., Parra-Tanoux D., Reyes L.F., Rodríguez A.H., Sancho I., Silva E., Socías L., Solé-Violán J., Vera-Alarcon M.Fuentes:scopusRisk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study
ArticleAbstract: Around one-third of patients diagnosed with COVID-19 develop a severe illness that requires admissioPalabras claves:Autores:Albaya-Moreno A., Bastidas A., Bodí M., Díaz A.M., Díaz E., Duque S., Estella A., Ferrer R., Figueroa W., Fuentes Y.V., García-Gallo E., Hernandez G., Ibáñez-Prada E.D., Jorge-García R., Loza-Vazquez A., Lozano-Villanueva J.L., Manuel Jibaja, Martín-Loeches I., Moreno G., Ospina-Tascón G.A., Ramirez-Valbuena P.C., Reyes L.F., Rodríguez A., Sancho I., Serrano-Mayorga C.C., Shankar-Hari M., Silva E., Socías L., Solé-Violán J., Varón-Vega F., Vera-Alarcon M.Fuentes:scopus